USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Thermally Targeted Therapeutics, Incorporated
Address:
2500 NORTH STATE ST
UMMC, Department of Biochemistry
Jackson, MS 39216-4505
Phone:
N/A
URL:
N/A
EIN:
262809239
DUNS:
807672899
Number of Employees:
1
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $139,375.00 1
STTR Phase I $224,881.00 1

Award List:

Thermally Targeted Delivery of Therapeutic Peptides

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$139,375.00
Agency:
HHS
Principal Investigator:
Drazen Raucher
Abstract:
DESCRIPTION (provided by applicant): Current treatment of solid tumors is limited by normal tissue tolerance, inherent tumor resistance to radiation or chemotherapy, and toxicity from systemic administration of antineoplastic agents. The result is a narrow therapeutic index for most current… More

STTR Phase I: Site specific delivery of cancer stem cells inhibitory peptides

Award Year / Program / Phase:
2013 / STTR / Phase I
Award Amount:
$224,881.00
Agency:
NSF
Principal Investigator:
Drazen Raucher – (601) 984-1510
Research Institution:
University of Mississippi Medical Center
RI Contact:
Jung Ryu
Abstract:
This Small Business Research (SBIR) Phase I project tests the application of a thermally responsive biopolymer, simultaneously to deliver breast cancer therapy and to prevent disease recurrence. Encouraging responses to multimodal treatments (surgery, radiotherapy, chemotherapy) are too often… More